Ildong Pharmaceutical's Postbiotics raw material listed in the US FDA NDI   Obtaining advantageous requirement for commercialization by being recognized for safety Utilized as a raw material for 'gQlab Postbiotics RHT'     Ildong Pharmaceutical (CEO Paul Woongsup Yun) has received NDI (New Dietary Ingredient) approval from the US FDA for its postbiotics raw material 'RHT3201'.     NDI approval is a procedure in which FDA reviews the information of the relevant ingredients to confirm the safety of functional raw material. Because it is strictly managed, only about 15% of the total number of applications passes the procedure.     Ildong Pharmaceutical's RHT3201 is 'postbiotics', which means metabolites produced by probiotics, and is a material obtained by the heat-treated 'Lactobacillus rhamnosus IDCC3201', a strain independently developed by Ildong Pharmaceutical.     In particular, the effectiveness related to skin immunity was proved through clinical test conducted by Ajou University Hospital, and it was the first domestic postbiotics to be recognized for its individually-recognized functionality by the Ministry of Food and Drug Safety.   An official from Ildong Pharmaceutical said, "In addition to the functionality of RHT3201, we have secured safety through FDA NDI approval."     Also, the official said, “When entering the domestic and overseas markets, we have not only secured public confidence in raw materials and finished products, but also shortened the time and the procedures required for registration”.         Currently, RHT3201 is being used in Ildong Pharmaceutical's "gQlab Postbiotics RHT," a health functional food helpful for intestinal health and skin immunity.     Ildong Pharmaceutical plans to develop and commercialize RHT3201 into raw materials, finished products, and medical materials by continuously pursuing various research and development.

 Ildong Pharmaceutical BiovitaㆍgQlabㆍMinimal Recipe, selected as “Good Design”     Ildong Pharmaceutical (CEO Yun Woongsup) announced on the 18th November that its Biovita, gQlab, and Minimal Recipes have been awarded as 'Good Design (GD) Products'.       'Selection of Good Design Products' is a system that is hosted and supervised by the Ministry of Trade Industry and Energy and the Korea Institute of Design Promotion, to select products and services with excellent design, and to give GD (Good Design) mark, which is certified by the government.     Biovita, the first Korea's lactic acid digestive for the whole family’s gut health introduced in 1959, has been renewed in 2020 by reinforcing strains and ingredients while saving the identity and features of existing Biovita.     Ildong Pharmaceutical explained that it focused on not only continuing the brand assets of Biovita, which has a long history and reputation, but also establishing the identity of the newly-made Biovita, and expressing product attributes with good raw materials and functions.     In particular, while applying the symbolic colors of Biovita, the light green and green, on the package colors, the letters B and O in the English name of Biovita are applied to form a smiling face and designed to be reminiscent of product names in pronunciation.     gQlab is a probiotics brand created based on Ildong Pharmaceutical's lactic acid bacteria technology, and the products selected for Good Design are 4 types of gQlab series for general distribution.     While maintaining the unity of the gQlab's brand system, the 4 gQlab series are designed to facilitate information delivery to consumers by properly arranging colors, emblems, pictograms, and texts according to the functions and ingredients of each sub-product.     Minimal Recipes Feminine Wipes is a functional tissue containing hyaluronic acid and dexpantheol. It is easy to carry and use by adopting a one-pack individual packaging and has a weak acidity which helps women have suitable PH(Percentage of Hydrogen) balance.     Minimal Recipes Feminine Wipes minimizes complicated and uncomfortable steps. By reflecting the brand philosophy of providing convenience to consumers, the package was designed using minimal elements and colors.     Especially, BI(Brand Identity) has been formed by applying English lowercase letters and Sans Serif fonts for concise images. And, the characteristics of the product are expressed by using a clean-refreshing white color and a mint color that offers a sense of moist and stable feeling.     Ildong Pharmaceutical said, “Design is also an important component of a brand.” "We plan to develop designs that can express product’s characteristics effectively and communicate with consumers."   

Ildong Pharmaceutical, “Achievements” of overseas business last year 60% increase over the previous year   Expanding Untact Marketing Exports of food supplements and cosmetics to China and Taiwan doubled     Ildong Pharmaceutical (CEO Yun Woongsup) achieved good results in overseas business last year through marketing diversification.     Ildong Pharmaceutical's overseas business performance in 2020 grew by about 60% compared to the previous year thanks to the increase in exports of pharmaceuticals, raw materials, food supplements, and cosmetics.         In the case of pharmaceuticals, there were special exports of emergency drugs related to Covid-19 such as antibiotics. And, the sales of synthetic pharmaceutical raw materials and vitamin raw materials, as well as existing finished drugs, were also expanded.     In addition, exports of consumer health care items such as food supplements including 'MyNi series' and functional cosmetics brand 'FIRSTLAB' to China and Taiwan have more than doubled compared to 2019.     In particular, the achievements were made by entering a famous online mall in China, trying live streaming sales through collaboration with Wanghong (an influential person in online and social media), and SNS marketing.     Ildong Pharmaceutical explained that it was attributed to actively search for and respond to market demand in a situation where it is difficult to secure a market due to the Covid-19 pandemic, while rapidly switching to untact marketing such as online and SNS instead of the conventional method.     Ildong Pharmaceutical said, “In not only the domestic but also the global market, the proportion of online and untact marketing is increasing.”, and added “We plan to expand the marketing through the Internet and SNS while reflecting the market and consumption trends, and focus our capabilities on promoting collaboration and finding partners such as local online malls and Wanghong”.     Also, they said, “We plan to increase efficiency by unifying organizations related to overseas business, and to expand markets in neighboring regions such as Southeast Asia and Russia.”

  Ildong Pharmaceutical has been assigned the Superior status based on the 2018 Sustainable Development Goals Business Index (SDGBI), which was established by the Association for Supporting SDGs for the United Nations (ASD)   The Association for Supporting SDGs for the United Nations (ASD) is a special consultative body for the Economic and Social Council (ECOSOC) established to support the implementation of UN’s Sustainable Development Goals.   Sustainable Development Goals are a collection of 17 global goals adopted by 193 UN member states adopted in 2015 at the 70th session of the UN General Assembly and the 2015 United Nations Sustainable Development Summit, covering social, environmental, and economic development issues that must be addressed for the prosperity of this planet and those living on it.  Under the leadership of the UN, the Goals officially came into force with a budget of approximately USD $45 which will be allocated to resolving different issues such as poverty, hunger, health, education, global warming, gender equality, water, sanitation, energy, urbanization, environment and social justice.   Based on these universal goals adopted by the international community, the SDGBI is designed to provide guidance to businesses on sustainable business management, while helping them to drive their operations toward the SDGs by analyzing each enterprise.   The SDGBI consists of 12 items and 45 indicator under the 4 major sectors – social, environment, economy, and policy, which are used in the analysis and ranking.   Given the Superior status based on the UN SDGBI, Ildong Pharmaceutical will continue to be a leading company in sustainable business management.

1. CPhI Japan 2017 -Date: April 18th ~ 21th -Country: Japan (Tokyo) -Booth No. N/A   2. Vitafoods Europe 2017   -Date: May 9th ~ 11th -Country: Switzerland (Geneva) -Booth No. A74   3. CPhI China 2017 -Date: June 20th ~ 22nd -Country: China (Shanghai) -Booth No.: E1 E10   4. Interphex Japan 2017 -Date: Jule 28th ~ 30th -Country: Japan(Tokyo) -Booth No. N/A   5. Vitafoods Asia 2017 -Date: September 5th ~ 6th -Country: Singapore -Booth No. N/A   6. CPhI Worldwide 2017 -Date: October 24th ~ 26th -Country: Germany(Frankfurt) -Booth No. 90G40 at Messe Frankfurt   There will be the booth for “ILDONG Pharmaceutical Co. Ltd. ” in these exhibitions. For the detailed information, please contact us at export@ildong.com   *Upload Date: October 16th, 2017.